Results 281 to 290 of about 744,744 (361)

Class 3 MAPK Mutation in Langerhans cell histiocytosis and Trametinib—Reporting Two Contrarian Responses

open access: yes
Pediatric Blood &Cancer, EarlyView.
Natalia Wojciechowska   +3 more
wiley   +1 more source

Biomarkers of Cellular Senescence in Type 2 Diabetes Mellitus

open access: yesAging Cell, EarlyView.
In cohorts of lean controls, obese participants without Type 2 Diabetes Mellitus (T2DM) and obese T2DM participants, we find that T‐cell expression of senescence biomarkers is altered only in the T2DM participants and not with obesity alone. Moreover, high T‐cell p16 expression in the T2DM participants is associated with impaired bone cortical indices.
Caroline Hoong   +9 more
wiley   +1 more source

Impact of age at first visit on glycolipid metabolism, bone metabolism, and fertility potential in patients with Klinefelter syndrome

open access: yesAndrology, EarlyView.
Abstract Background Classic Klinefelter syndrome (KS) is characterized by one extra X chromosome (47, XXY), leading to hypergonadotropic hypogonadism and higher risk of alterations in glycolipid homeostasis, cardiovascular diseases, and low bone mineral density. Most frequently, KS is diagnosed in adulthood because of infertility.
Giordana Ferraioli   +7 more
wiley   +1 more source

Giant Cell Tumor of the Proximal Femur with Pathological Fracture of Femoral neck. [PDF]

open access: yesJ Orthop Case Rep
Gupta G   +5 more
europepmc   +1 more source

Total Neoadjuvant Therapy Versus Conventional Neoadjuvant Therapy for Rectal Cancer: Cost Analysis in a Public Healthcare System

open access: yesANZ Journal of Surgery, EarlyView.
Costs of neoadjuvant therapy. ABSTRACT Purpose Total neoadjuvant therapy (TNT) has become the standard of care in locally advanced rectal cancer, but its economic impact is unclear. This study compares the cost of TNT with conventional neoadjuvant therapy (CNT), consisting of either short‐course radiotherapy or long‐course chemoradiotherapy, within a ...
Ishraq Murshed   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy